Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006741
Filing Date
2025-05-07
Accepted
2025-05-07 16:15:25
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20250331x10q.htm   iXBRL 10-Q 1148885
2 EX-31.1 gbio-20250331xex31d1.htm EX-31.1 7517
3 EX-31.2 gbio-20250331xex31d2.htm EX-31.2 8497
4 EX-32.1 gbio-20250331xex32d1.htm EX-32.1 4623
5 EX-32.2 gbio-20250331xex32d2.htm EX-32.2 4888
  Complete submission text file 0001558370-25-006741.txt   5469174

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20250331.xsd EX-101.SCH 42660
7 EX-101.CAL gbio-20250331_cal.xml EX-101.CAL 47255
8 EX-101.DEF gbio-20250331_def.xml EX-101.DEF 161708
9 EX-101.LAB gbio-20250331_lab.xml EX-101.LAB 331757
10 EX-101.PRE gbio-20250331_pre.xml EX-101.PRE 274550
66 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250331x10q_htm.xml XML 868193
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 25921581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)